TrialPharmacoEconomics2021

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective.

Adnan Alsumali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.